Understanding the question
The client is newly started on the standard intensive phase of tuberculosis treatment:
2HRZE. This stands for two months of
isoniazid (H),
rifampicin (R),
pyrazinamide (Z), and
ethambutol (E). The question asks which statement indicates a need for further teaching, meaning the client has misunderstood something important about the drugs or home infection control.
The correct answer is statement 3 because orange urine is a normal, expected effect of rifampicin, not a reason to stop treatment. Stopping the drugs because of this harmless discoloration would interrupt therapy and increase the risk of treatment failure, relapse, and drug resistance.
---
Why orange urine is not a danger sign
Rifampicin and its metabolites are highly pigmented. They are excreted through the kidneys, liver, sweat glands, and lacrimal glands. This causes body fluids such as urine, sweat, tears, and sometimes saliva to turn an orange-red color. This effect begins shortly after starting the drug and continues throughout treatment.
The discoloration is pharmacologically expected and does not indicate liver injury, kidney damage, or any other organ toxicity. It is not a hypersensitivity reaction. The client should be reassured that this is harmless and that they must continue taking all tablets as prescribed.
If the client stops rifampicin because of orange urine, the consequences are serious.
Key point! Interrupted treatment allows surviving mycobacteria to multiply again. This can lead to prolonged infectiousness, clinical relapse, and the emergence of drug-resistant strains. Non-adherence to tuberculosis treatment is a major driver of treatment failure and acquired drug resistance.
---
When stopping the drugs is correct
Statement 1 describes yellowing of the eyes, which is
scleral icterus. This is a sign of
hyperbilirubinemia, most commonly caused by drug-induced liver injury. In the 2HRZE regimen, the main hepatotoxic agents are
isoniazid,
rifampicin, and
pyrazinamide. Liver injury can progress to severe hepatitis if the offending drugs are continued.
Yellow eyes or skin, dark urine, persistent nausea or vomiting, abdominal pain, and unexplained fatigue are warning signs that require withholding the anti-TB drugs and immediate medical evaluation. The client’s statement that they would stop the tablets and go to the clinic for yellow eyes is therefore correct and shows good understanding.
Watch out! Do not confuse the orange-red discoloration from rifampicin with the dark, tea-colored urine of bilirubinuria. Orange urine is bright and reddish-orange; bilirubinuria is typically dark brown or cola-colored. The client’s statement about orange urine is the one that reflects a misunderstanding.
---
Home infection control and contact screening
Statement 2 is correct. Pulmonary tuberculosis is transmitted through airborne droplet nuclei. Household contacts, especially those living in crowded conditions, are at high risk of infection. All close contacts should be evaluated for latent TB infection or active disease. This is a standard component of TB control programs.
Statement 4 is also correct. During the first two weeks of effective treatment, the client remains potentially infectious.
Sleeping in a separate room with an open window reduces the concentration of infectious droplet nuclei in shared household air. Natural ventilation dilutes and removes airborne bacilli, lowering transmission risk to family members. After two weeks of adherent treatment with clinical improvement, the client is generally considered much less infectious.
---
Why adherence education matters
Patient education is a core nursing intervention for tuberculosis. It improves understanding of the disease, the purpose of each drug, expected side effects versus danger signs, and the importance of completing the full course.
Education that distinguishes harmless effects such as orange urine from serious adverse events such as jaundice helps prevent unnecessary treatment interruption. Clear teaching about infection control measures and contact screening also protects the household and the community.
The table below summarizes the key distinctions the client must understand.
| Finding | Cause | Expected or dangerous | Correct action |
|---|
| Orange-red urine, sweat, tears | Rifampicin pigment excretion | Expected and harmless | Continue all drugs; reassure client |
| Yellow eyes or skin | Drug-induced hepatotoxicity (H, R, Z) | Dangerous | Stop drugs; refer immediately |
| Dark, tea-colored urine | Bilirubinuria from liver injury | Dangerous | Stop drugs; refer immediately |
| Persistent nausea, vomiting, abdominal pain | Possible hepatitis | Dangerous | Stop drugs; refer immediately |
The client who plans to stop treatment for orange urine has not yet understood that this is an expected effect of rifampicin. That misunderstanding, if acted upon, would directly undermine treatment success and increase the risk of drug-resistant tuberculosis.